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Abstract
Background: The study of protein-small molecule interactions is vital for understanding protein function and for 
practical applications in drug discovery. To benefit from the rapidly increasing structural data, it is essential to improve 
the tools that enable large scale binding site prediction with greater emphasis on their biological validity.
Results: We have developed a new method for the annotation of protein-small molecule binding sites, using inference 
by homology, which allows us to extend annotation onto protein sequences without experimental data available. To 
ensure biological relevance of binding sites, our method clusters similar binding sites found in homologous protein 
structures based on their sequence and structure conservation. Binding sites which appear evolutionarily conserved 
among non-redundant sets of homologous proteins are given higher priority. After binding sites are clustered, position 
specific score matrices (PSSMs) are constructed from the corresponding binding site alignments. Together with other 
measures, the PSSMs are subsequently used to rank binding sites to assess how well they match the query and to 
better gauge their biological relevance. The method also facilitates a succinct and informative representation of 
observed and inferred binding sites from homologs with known three-dimensional structures, thereby providing the 
means to analyze conservation and diversity of binding modes. Furthermore, the chemical properties of small 
molecules bound to the inferred binding sites can be used as a starting point in small molecule virtual screening. The 
method was validated by comparison to other binding site prediction methods and to a collection of manually curated 
binding site annotations. We show that our method achieves a sensitivity of 72% at predicting biologically relevant 
binding sites and can accurately discriminate those sites that bind biological small molecules from non-biological 
ones.
Conclusions: A new algorithm has been developed to predict binding sites with high accuracy in terms of their 
biological validity. It also provides a common platform for function prediction, knowledge-based docking and for small 
molecule virtual screening. The method can be applied even for a query sequence without structure. The method is 
available at http://www.ncbi.nlm.nih.gov/Structure/ibis/ibis.cgi.
Background
The physical interactions between proteins and other
molecules in protein crystal structures provide crucial
insights into protein function. It is precisely these struc-
tures that enable researchers to study interactions in
atomic detail, and find out, for example, how a specific
mutation in a protein affects its function, or how a few
atom modifications in a small molecule might lead to a
more effective drug. With the large number of available
crystal structures (nearly 60,000 currently in the RCSB
Protein Data Bank), it is of great importance to improve
the tools available for study of these interactions.
Moreover, a powerful method of inference can be used
to predict function and interactions. It is based on the
observation that homologous proteins have similar func-
tions and often interact with their small molecules in a
similar manner. Thus it is possible to infer protein-small
molecule interactions even if there are no crystal struc-
tures available for a particular protein of interest, as long
as there are structures of sufficiently close homologs.
Recent estimates suggest that the majority of Entrez Pro-
tein sequences have homologs with a known structure
[1,2], thereby providing a reasonable chance to find rele-
vant interactions via structures for protein sequences.
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Homology inference methods, although powerful, have
certain limitations. Common descent does not necessar-
ily imply similarity in function or interactions; and anno-
tations transferred from one protein to a homolog may
result in incorrect functional or interolog assignment at
larger evolutionary distances [3-6]. To verify and guide
annotations, it is often essential to ensure close evolu-
tionary relationships, and at the same time characterize
the details of interactions in terms of binding site similar-
ity. Current binding site prediction methods can be sub-
divided into several major categories: those which use
evolutionary conservation of binding site motifs [7-9],
those which use information about a structure of a com-
plex [10-12], and docking and other methods [13,14].
Structure-based methods use detailed knowledge of the
protein structure to identify binding sites on the basis of
the physico-chemical properties of individual residues,
their electrostatic contribution, and their location in the
3D structure [15-26].
A number of methods and servers have been developed
for predicting protein function by identifying similarities
in sequence and structural features of binding pockets in
homologous proteins, or evolutionary constraints on res-
idues [27], or by using threading and other approaches
[20,28-39]. The main goal of these methods is to provide
functional annotation for proteins out to the most distant
homology relationships. FINDSITE  [40], for example,
looks for structural templates with bound small mole-
cules for a query protein using threading. The templates
are superimposed and the centers of mass of the bound
small molecules are clustered to annotate putative bind-
ing sites on the query. Threading based methods,
although capable of recognizing distant functional rela-
tions, are limited by the complexity of model building and
low reliability of function transfer associated with distant
homology [41,42].
Firestar  [31] predicts functionally important residues
based on PSI-BLAST [43] alignments between the query
sequence and structures with functional information
derived from the PDB and the Catalytic Site Atlas [44].
PHUNCTIONER  [20] uses sequence profiles based on
clustered sequences with matching GO [45] terms;
potential binding sites are detected from sequence con-
servation. This method is capable of inferring the loca-
tion of highly conserved small molecule binding sites, but
m i g h t  b e  q u e s t i o n a b l e  i f  t h e  c o n s e r v a t i o n  o f  s i t e s  i s
caused by factors other than binding.
Transitive annotation of small molecule binding sites is
also possible by detection of functional domains in the
query protein sequence through BLAST heuristics and
mapping the functionally important residues and/or fea-
tures from the domain family members [30,46].
There are a few other methods that directly detect
small molecule binding sites via geometric analysis of
protein structures. These methods include LIGSITEcsc
[29], CAST [47], PASS [48], SURFNET [49], SCREEN
[50], and ConCavity [51]. All of these algorithms attempt
to identify solvent-accessible pockets formed by surface
residues on the protein, and to rank those pockets (for
example by volume), in order to assign the most highly
ranked pockets as the predicted/putative small molecule
binding sites. LIGSITEcsc, SURFNET, and ConCavity use
a more complex ranking function that takes into account
residue conservation of binding site residues. These geo-
metric methods are reasonably accurate, achieving suc-
cess rates of 60-70% in correctly identifying small
molecule binding sites. In their evaluation of LIGSITEcsc,
the authors showed that their algorithm outperformed
the other three methods on a test set of 48 structures [29].
The SCREEN method identifies binding sites geometri-
cally, and also computes feature vectors that are used by
machine learning techniques. SCREEN is included in a
suite of powerful modeling tools for functional annota-
tion [52]
Recently we have developed a new database and
method called "IBIS" (Inferred Biomolecular Interaction
Server [53], http://www.ncbi.nlm.nih.gov/Structure/ibis/
ibis.html) which enables researchers to conveniently
study biomolecular interactions that have been observed
in protein structures and through inference by homology
to formulate predictions/hypotheses for biomolecular
interactions, even if the data for specific biomolecules is
not available. Therefore, IBIS can be considered a
resource for functional annotation of proteins that have
relevant homologs in the PDB [54]. An input protein
sequence may or may not have a structure itself; if not, it
is assigned to the most closely related structure(s) using
BLAST. IBIS can identify and infer a protein's interaction
partners together with the locations of the corresponding
binding sites on the protein query. It provides annota-
tions of binding sites for proteins, small molecules
(chemicals), nucleic acids, peptides and ions. In this
paper we describe the method used in IBIS to annotate
protein-small molecule interactions. To ensure biological
relevance of binding sites, IBIS clusters similar binding
sites found in homologous proteins based on conserva-
tion of sequence and structure of the binding site resi-
dues. Binding sites which appear evolutionarily
conserved among non-redundant sets of homologous
proteins are given higher priority. Additionally, binding
site clusters are validated by comparing them with avail-
able binding site annotations from a manually curated
subset of the CDD database [55,56], and sites with non-
biological small molecules are excluded. After bindingThangudu et al. BMC Bioinformatics 2010, 11:365
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sites are clustered, position specific score matrices
(PSSMs) are constructed from the corresponding binding
site alignments. Together with other measures, the
PSSMs are subsequently used to rank binding sites to
assess how well they match the query, and to gauge the
biological relevance of binding sites with respect to the
query.
A critical difference between our method and others is
that IBIS pays particular attention to ensuring the biolog-
ical relevance of binding sites, and homology between the
unknown query sequence and the known structures of
protein complexes. Our method might miss some remote
similarities which could be detectable, for example by
FINDSITE, but in exchange IBIS's top ranked annota-
tions should be considered highly reliable. Unlike other
methods, IBIS does not filter out similar structures to
speed up the search process, but accounts for all struc-
tures so that interesting small molecule binding com-
plexes are easily accessible. Our method derives the
actual binding sites from observed structures, and groups
them to account for variations in the binding site residues
due to differences in small molecule size and conforma-
tions. This is essential for proteins which are important
drug targets, as they have often been co-crystallized with
a great variety of inhibitors. The clustering (grouping) of
binding sites by similarity is very important because it
identifies the distinct binding modes and allows for an
easier interpretation of the results, despite the great
growth in the amount of structure data over the last sev-
eral years. As we have shown, it is possible to do the clus-
tering automatically and in a biologically meaningful way.
Results
Annotation of protein chains with observed and inferred 
binding sites
There are about 28000 PDB entries with observed small
molecule binding sites and about 56000 protein chains.
The total number of observed small molecule binding
sites is about 91000 and approximately 67000 of these
represent biologically relevant small molecules(i.e.
around 24000 small molecules represent crystallization
agents). Small molecule binding is a specific feature that
plays a crucial role in the protein function. About 64% of
protein chains in the PDB bind to a single small molecule
and 95% bind to no more than four small molecules (Fig-
ure 1a). Likewise, the binding site pockets are rather
small compared to the size of their functional domains.
The binding sites are usually less than 25 residues and
55% of the binding sites in the current study are smaller
than 10 residues (Figure 1b). Our algorithm inferred
binding sites for 92000 protein chains and the overall
average number of binding site clusters inferred per chain
is 6.5 (Figure 1c) whereas the average number of biologi-
cally relevant binding site clusters inferred per chain is
about 4.
One of the important features of this method is that it
does not exclude redundant sequences bound to different
small molecules. For example, to account for all specific
interactions of various drugs targeting the Kinase ATP
binding site, it is imperative to consider all the protein
sequences even if they are identical.
We validated the IBIS method by comparing the
obtained annotations to the manually curated CDD
annotations and to other different methods which use
geometry of binding pockets and/or sequence conserva-
tion of binding sites. It should be mentioned that since
the IBIS method is based on different types of structural
evidence, the notion of false positives might not be valid
in many cases.
Validation of the IBIS method using the Conserved Domain 
Database
To test the ability of our method to successfully infer the
biologically relevant binding sites, a validation procedure
was implemented using the manually curated Conserved
Domain Database (CDD) [56] alignments and the func-
tional features recorded in it as a standard of truth. Man-
ually curated functional site annotations in CDD have
been extracted from the published literature or derived
from manual interpretation of individual three-dimen-
sional structures. Altogether 49% of the proteins with
observed small molecule binding sites have CDD small
molecule binding site conserved annotations whereas
over 55% of the proteins with inferred binding sites have
at least one site overlapping with CDD annotated binding
site annotation.
In our analysis we used the CDD release 2.16 contain-
ing 4092 protein chains. We chose representative protein
chains purged at the 25% sequence identity level. In this
jackknifing experiment, the query protein and its identi-
cal homologs are omitted from clustering. Altogether 486
representative chains had at least one structurally similar
non-identical homolog which had observed protein-small
molecule binding sites. Figure 2a shows how well our
method can retrieve the CDD annotated binding sites at
the top ranks by calculating the fraction of true positives
(sensitivity) or percentage of correctly annotated binding
sites (overlap between CDD and IBIS annotated binding
sites should be at least 50%). For 207 of these there was
only one inferred binding site (cluster) detected, and by
default these will always be ranked first. There remain
279 examples which have at least two IBIS binding sites,
209 (75%) of these were ranked first, and 49 were ranked
second, so that 258 (92%) were ranked either first or sec-
ond (Figure 2b).Thangudu et al. BMC Bioinformatics 2010, 11:365
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Figure 1 Statistics of small molecules and their binding sites observed in protein structure complexes. a) Number of small molecules and 
binding sites observed per protein chain, b) size of the observed binding sites, c) histogram showing the number of observed and inferred binding 
sites with plotted versus the fraction (%) of protein chains having these sites.
Figure 2 Biological validity of the IBIS inferred binding sites. a) Histogram showing the frequency of protein chains as function of their biological 
relevancy as suggested by overlap of the inferred binding sites with CDD conserved feature annotation. b) Percentage of proteins with their inferred 
sites having their 1st and 2nd rank clusters with CD annotations; 165 proteins have only one predicted site.Thangudu et al. BMC Bioinformatics 2010, 11:365
http://www.biomedcentral.com/1471-2105/11/365
Page 5 of 12
Since there are a number of proteins which do not have
CDD annotations, IBIS inferred binding sites may be bio-
logically relevant in these cases.
Validation of ranking scheme: discriminating between 
biological and non-biological chemicals
We used the same set of protein queries (604 chains) to
evaluate our method using structures which contained
both biological and non-biological small molecules (see
Additional file 1 Table S1). Our goal is to assess how well
our ranking scheme distinguishes between the two
groups of binding sites: those containing biological versus
non-biological small molecules. If all the bound small
molecules in an inferred binding site are non-biological,
it is deemed as non-biological. To address this, we applied
a linear discriminant analysis which constructs a discrim-
inant function that divides the parameter space into
regions so as to separate the groups as distinctly as possi-
ble. The method computes the posterior probability of
group membership for each observation, and assigns the
observation to the group that has the highest probability.
As a result, a classification matrix is produced, which
gives the fraction of observations correctly assigned to
each group by the discriminant function. In our case, a
good classification would be quantified by high fractions
for both correctly predicted biological binding site clus-
ters and correctly predicted non-biological binding site
clusters. We found that our method correctly classifies
87% of biological clusters and 85% of non-biological clus-
ters.
Validation of IBIS method by comparison with - geometric 
methods
To further validate the prediction ability of our method
we compared it with several widely used geometry and
energy-based approaches discussed in a recent study [57]
which includes LIGSITEcsc [29], PASS [48], Q-SiteFinder
[28], Surfnet [49]. We used 44 out of 48 proteins from this
paper which have structure homologs with at least 30%
sequence identity and also have both small molecule-
bound and unbound structures.
For each method tested, the top ranked predicted sites
for the unbound structure are compared with the
observed binding sites in the bound structure of a pro-
tein-small molecule complex of a homolog. Table 1 shows
the sensitivity of retrieval of the true observed sites at the
top three ranks. To measure the sensitivity of retrieval of
bound structures at different levels of similarity between
the unbound query and bound structure from the data-
base, we selected from the test set only those unbound-
bound pairs which are within a given similarity range (no
more than 80, 90, or 100% identity) and denoted them
IBIS80, IBIS90 and IBIS100. For example, the IBIS90 dataset
contains unbound query proteins for which the average
sequence identity between the unbound protein and
members of the binding site clusters containing the
bound homolog is no more than 90%. It is difficult if not
impossible to define false positives in our case since there
are many binding site clusters which are biologically rele-
vant (for example have a significant overlap with the
manually curated CDD functional annotations) but at the
same time do not match the binding site of the bound
form of the protein from the test set. This happens if, for
example, there are multiple binding sites/pockets in the
protein which bind different small molecules and have
distinct functions. As can be seen from this table IBIS
performance is similar to the LIGSITEcs method which
uses sequence conservation and reaches about 72% sensi-
tivity. Overall we found that a total of 31 proteins (70%)
from the test set have at least one of their IBIS predicted
sites overlap with CDD binding site annotation. This sug-
gests that IBIS successfully uses the knowledge of the
structure complexes of homologs to predict and rank the
relevant sites. The complete details of the prediction
results can be seen in Additional file 1 Table S2.
All of these approaches, although they perform reason-
ably well, are limited by the requirement of differentiating
true positives from false positives. Introducing sequence
conservation need not necessarily improve the prediction
accuracy and could be a source of error, leading to over
prediction of the binding site area [58]. IBIS on the other
hand predicts only a handful of small molecule binding
sites with high probability of being biologically relevant.
On average our method predicts 4 'biologically relevant'
binding sites per protein chain and over half of all pre-
dicted sites map to CDD curator annotations.
Knowledge-based docking using IBIS, an example
To demonstrate the effectiveness of IBIS as a knowledge-
based prediction system, we compared our method with
an established reverse docking approach. Cai and
Table 1: Prediction sensitivity (%) of the top three 
predictions by different geometric approaches and their 
comparison to IBIS.
Method* Top1 Top2 Top3
IBIS100 73 89 89
IBIS90 75 91 91
IBIS80 72 88 88
LIGSITEcs 71 79 85
PASS 58 67 75
Q-SiteFinder 52 60 75
SURFNET 42 58 62
*IBIS100, IBIS90, IBIS80 dataset contains unbound query proteins for 
which the average sequence identity between the unbound protein 
and members of the binding site clusters containing the bound 
homolog is no more than 100%, 90% and 80% respectively.Thangudu et al. BMC Bioinformatics 2010, 11:365
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coworkers [59] employed a reverse docking method to
find a potential target protein for a natural product: N-
trans-caffeoyltyramin in the genome of Helicobacter
pyroli. Initially all potential binding proteins of N-trans-
caffeoyltyramin were screened from a database of poten-
tial drug targets with known structures from the Protein
Data Bank using the reverse docking approach TarFis-
Dock [60]. Only two proteins from the H.pyroli genome
were found by the TarFisDock method: diaminopimelate
decarboxylase (DC) and Peptide deformylase (PDF).
After enzymatic validation, only the PDF protein was
found to be a probable drug target. The crystal structure
complex of N-trans-caffeoyltyramin with PDF suggested
a highly selective binding in the PDF binding pocket.
We attempted to identify the binding sites of N-trans-
caffeoyltyramin on the PDF protein sequence. The closest
homolog for H.pyroli PDF is P.aeruginosa PDF which has
45% sequence identity and has been used as a template
for inferring the interactions by IBIS. The top ranked and
highly conserved inferred binding site of P.aeruginosa
P D F  w h e n  m a p p e d  o n t o  H . p y r o l i  P D F  i s  i n  c o m p l e t e
agreement with the native/experimentally determined
binding site of the N-trans-caffeoyltyramin - PDF com-
plex (Figure 3).
Discussion
A researcher interested in the function of a specific pro-
tein will usually be concerned not only with the availabil-
ity of any functional annotation, but also with the
reliability of such information. The most reliable source is
experimental data on the protein function but despite the
growth of the protein sequence and structure databases,
there remains only a small fraction of proteins whose
functions have been experimentally characterized. In this
paper we present a method which provides the informa-
tion on protein function annotation through the identifi-
cation of protein binding sites. The current approach
attempts to interlink sequence conservation with struc-
tural diversity in deciphering protein function. We specif-
ically focus on protein small molecule binding sites and
their biological relevance for protein function. Our
method derives the actual binding sites from the struc-
tures of all the homologs and groups them based on
sequence and structural similarity. For example, to
account for all specific interactions of various drugs tar-
geting the Kinase ATP binding site (see Additional file 1
Table S3), it is imperative to consider all the protein
sequences even if some of them are identical. Such group-
ing ensures their biological relevance and at the same
Figure 3 Tyrosine kinase homologoues with varying degrees of sequence conservation with different small molecules in their ATP-binding 
pocket. (a) Ephb2 Receptor Kinase domain with ADP. (b) Syk Tyrosine Kinase Domain in complex with Gleevec. (c) Ephb2 Receptor Tyrosine Kinase 
with Adenine.Thangudu et al. BMC Bioinformatics 2010, 11:365
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time accounts for variations in the binding site residues
due to differences in small molecule sizes and conforma-
tions. By using all available structures of close homologs,
IBIS provides a great opportunity for analyzing the diver-
sity of binding modes. Figure 4, for example, shows the
conserved tyrosine kinase fold with varying degrees of
sequence similarity but sharing a highly conserved ATP
binding site occupied by different small molecules.
Recently , it was estimated that over two-thirds of all
protein sequences in the GenBank database have at least
one structure homolog [1,2]. As the on-going structural
genomics initiative continues to close the sequence-
structure gap, our method might be very useful for anno-
tating proteins with unknown function and structure.
Moreover, the location of putative binding sites provides
guidance for the protein docking methods for drug
design. We have assessed the reliability of our method by
direct comparison with the binding site annotations from
literature and manual curation and have shown that in
the great majority of cases, the method detects and ranks
the manually annotated binding site cluster at the first or
second rank. This is achievable for a number of reasons,
such as using a sufficient level of similarity between the
unknown query and its homologs with the known bind-
ing sites, accurate clustering of small molecule binding
sites using a reasonable similarity measure, and applying
a deliberately designed ranking scheme that distinguishes
the non-biological from the biologically relevant binding
sites.
We have also compared our method with several widely
used geometry and energy-based approaches to predict
small molecule binding sites. As we have shown, the per-
f o r m a n c e  o f  o u r  p r e d i c t i o n  m e t h o d  i s  v e r y  s i m i l a r  t o
popular geometric approaches. Moreover, one of the
advantages is that our method can be applied even for a
query sequence without structure, which is not the case
for those binding site prediction methods which explicitly
rely on the specific features of binding pocket geometry.
Using remote homology for functional inference is
often based on the general assumption that there is a neg-
ative correlation between small molecule binding site
similarity and overall sequence similarity. However, small
molecule binding site similarity is much more compli-
cated with many examples of strikingly similar binding
sites with low (<30%) overall sequence identity and also
very weakly similar binding sites with high overall
sequence identity [61]. Likewise, the similarities of small
molecule binding sites across different protein folds,
although providing new insights, leads to new challenges
in deciphering the functional relevance. Large-scale auto-
mated function prediction methods are often limited by
the lack of sufficient understanding of biological function
and also by the quality of structure data. Hence, through
the IBIS approach, we strive to limit the false positive rate
by employing a conservative sequence similarity thresh-
old of at least 30% over the structurally superimposed
regions of homologs. It is often possible that the protein-
small molecule crystal state may correspond to a global
minimum of free energy where biologically relevant
interactions are difficult to distinguish from non-specific
contacts. For example, a recent estimate suggests some
20% of dimeric structures in PDB may be crystallization
artifacts [62]. The elaborate scoring scheme of our
method based on recurrence and evolutionary conserva-
tion, along with the list of non-biological small molecules,
tends to de-emphasize the artifactual interactions and
ranks such sites near or at the bottom of the list.
Figure 4 Mapping of the inferred binding site. Inferred binding site of peptide deformylase P.aeruginosa (PDB:1IX1) mapped onto the sequence 
of Helicobacter pyroli and its agreement with the observed binding site in N-trans-caffeoyltyramin-PDF complex (PDB: 1EW5). MMDB residue number-
ing is used which starts from the beginning of the corresponding GenBank protein sequence.Thangudu et al. BMC Bioinformatics 2010, 11:365
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Furthermore, the chemical properties of small mole-
cules bound to the inferred binding sites can be used as a
starting step in small molecule virtual screening. The
PubChem compound database [63] mapping of IBIS
small molecules accomplishes a preliminary step in small
molecule virtual screening by clustering the similar
chemicals into structurally unique compounds. The func-
tional groups of the small molecules binding in a com-
mon binding site of evolutionarily related proteins are
likely conserved. Recently it was shown that sequence
and structure conservation of the binding site residues
contacting these anchor functional groups is significantly
higher than those contacting variable regions [40]. IBIS,
thus provides a common platform for function predic-
tion, knowledge-based docking and also for small mole-
cule virtual screening.
Conclusions
Finding small molecule binding sites that specify protein
f u n c t i o n  i s  o f  g r e a t  i m p o r t a n c e  i n  d r u g  d e v e l o p m e n t .
Here we proposed a method to decipher the function of
an unknown protein by interlinking sequence conserva-
tion with structural diversity of its homologs. To facilitate
validation of the inferred binding sites from homologs,
we developed an elaborate scoring scheme that can accu-
rately distinguish biologically relevant sites. The method
has been implemented as a web server, IBIS (Inferred
Biomolecular Interaction Server - http://www.ncbi.nlm.
nih.gov/Structure/ibis/ibis.cgi) to facilitate accurate, effi-
cient and high-throughput function prediction.
Methods
W e  u s e d  t h e  N C B I  M o l e c u l a r  M o d e l i n g  D a t a b a s e
(MMDB) [64] as a source of data on protein complexes.
The automated MMDB processing of PDB files includes
steps such as deposition of the protein sequences into
GenBank [65], deposition of small molecules into Pub-
Chem [63], addition of corresponding links to these data-
bases in the MMDB records, also links to citations and
references in PubMed, and Entrez indexing for quick
searching.
Below we describe different steps of processing, includ-
ing defining observed interactions from structures,
inferred interactions from homologs, clustering binding
sites and their ranking in terms of biological relevance
with respect to the query protein.
Defining observed interactions
In the current release of the Molecular Modeling Data-
base (MMDB) [64], there are about 28000 entries with
bound small molecules. The resulting 39000 small mole-
cules are bound to about 56000 protein chains in total. A
small molecule is defined as any non-polypeptide, non-
nucleic acid molecule in the structure complex or any
molecule with a sufficient number of non-standard
amino acid/nucleic acids and without an assigned Gen-
Bank identifier from NCBI. All the small molecules are
standardized in the PubChem database [63] and have
valid substance and compound identifiers. In this work
we do not consider small molecules that are smaller than
5 heavy atoms or those having molecular weight outside
the range of 70-800 Da. Small molecules such as metal
ions often play role as crystallization agents, and there-
fore ions are not considered in this paper.
The filters by atom count and molecular weight only
partially remove non-biological small molecules (i.e. buf-
fers, salts, detergents, solvents, and ions added for the
purpose of crystallization and/or purification). These
non-biological molecules sometimes mimic natural small
molecules and tend to bind in functional/active sites of
proteins. For validation purposes we used a list of poten-
tial non-biological small molecules which has been col-
lected from the literature (see Additional file 1 Table S1)
[30,66,67].
We define a protein residue to be in contact with a
small molecule if there is at least one (heavy) atom of the
residue within 4.0Å of some atom from the small mole-
cule. For most pairs of atoms, this threshold corresponds
to the sum of their van der Waals radii plus a tolerance of
about 0.5Å to allow for coordinate errors in structure
determination. For manual curation of the Conserved
Domain Database (CDD) a similar contact definition is
used for defining protein-small molecule contacts. We
retain only those protein-small molecule complexes
which have at least five interacting protein residues. We
define "binding site" as a set of residues on a given protein
chain which are in contact with a given small molecule.
Each MMDB entry is analyzed, and all pairs of biomole-
cules consisting of a protein chain and small molecule in
contact with that chain are retained for further analysis.
It should be mentioned that a small molecule can be
bound to a single domain or multiple domains which
could come from more than one protein chain in the PDB
record. Almost half of all the small molecules in the PDB
are bound by more than one domain with <75% of all
contacts to any single domain [66]. However, using
domains as structural units would necessitate automatic
domain decomposition methods in many cases [68,69],
and the domain boundaries chosen could affect the
results. To circumvent the potential technical difficulties
in using domains as the structural unit in recording the
observed/physical interactions, we use only complete
protein chains for defining protein-small molecule inter-
actions. Small molecules binding to multiple protein
chains entail even more technical difficulties. For exam-
ple, simultaneous superposition of multiple chains would
need to be checked to ensure similarity of binding sites.
Therefore, when multiple chains are involved in a bindingThangudu et al. BMC Bioinformatics 2010, 11:365
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site, if one of the chains includes 75% or more of the con-
tacts, then we define only one binding site and assign it
only to that particular chain. Otherwise, we define sepa-
rate binding sites on each of the chains. The latter situa-
tion is relatively rare as only about 15% of the proteins in
the current PDB release have small molecule interactions
that fall into this category.
Inferring interactions from homologs
To ensure the biological relevance of binding sites, they
are clustered and their sequence and structural similarity
is assessed. An overview of the process is shown in Figure
5. Here are the important details concerning the main
steps in the processing.
1) Collecting homologs with bound small molecules
To infer interactions based on homology we collect pro-
teins which are structurally similar to a given query pro-
tein and have at least 30% sequence identity to the query
(we refer to them as "homologous structure neighbors").
Structure neighbors for all PDB/MMDB entries have
been pre-computed by the VAST algorithm [70] and
stored in the PubVast database. Then we retrieve
observed interactions for all structure neighbors (includ-
ing the query protein). No sequence redundancy filter is
applied to remove structures because there are often
many structures of the same protein with different bound
small molecules, and we may wish to study any of these
cases. Since the alignments may contain gaps, we retain
only those instances where at least 75% of the residue
contacts with the small molecule occur within the struc-
ture alignment footprint of the query and neighbor.
2) Measuring binding site similarity
In order to cluster the binding sites of the homologous
structure neighbors, it is necessary to construct their
alignment and define a similarity measure. We construct
the alignment between the structure neighbors A and B
by composing the alignment from structure neighbor A
to the query, with the alignment from the query to struc-
ture neighbor B. It is necessary to construct this align-
ment by composing through the query, because
oftentimes the neighbors A and B will be more closely
related to each other than to the query, in which case the
"direct" alignment between them will be more extensive
than the one through the query, and so it could include
binding sites or interface residues that are not relevant to
the query. To capture the similarity of the binding sites,
the similarity measure includes both the structural equiv-
alency and sequence similarity. The similarity score
between two positions i  and  j  of two binding sites is
defined as:
SH a a w ij i j ij ij ij =+ + − (,) ( ) ΔΔ Δ f 1 (1)
Figure 5 Overview of the IBIS binding site annotation procedure.Thangudu et al. BMC Bioinformatics 2010, 11:365
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where H is the element of the BLOSUM62 matrix cor-
responding to the aligned amino acids in positions i and j;
Δij is equal to 1 if two positions are aligned and 0 other-
wise.  θ  is an additional weight of "+1" added to each
structurally equivalent position. w is a gap penalty of "-4",
to mimic the most unfavorable substitution score from
BLOSUM62 matrix, which showed the best performance
in our preliminary studies. The overall similarity score
between two binding sites is calculated by summing up Sij
over all positions in the gapped alignment. To facilitate
comparison of scores from different alignments, the raw
score is converted to a bit score with the statistical
parameters λ and K previously defined in the BLOSUM
scoring system.
The similarity score is then converted into a conserva-
tion score CS by dividing by the maximum of the bit
scores when the binding sites are scored against them-
selves.
3) Clustering of binding sites
Based on the calculated conservation score CS, the bind-
ing sites of the homologs are clustered using a complete-
linkage clustering algorithm, which considers the dis-
tance between two clusters to be equal to the maximum
distance between their members. A distance cutoff value
to define the clusters is chosen using a free energy func-
tion defined previously. This function F is formulated to
maximize the mean similarity of members within a clus-
ter and minimize the complexity of the description pro-
vided by cluster membership [71].
where T is the temperature factor, S(i, j) is the similarity
score between binding site i and binding site j in each
cluster, C represents a cluster, |C| is the number of bind-
ing sites in the cluster C, and N is the total number of
binding sites clustered. The temperature T is a parameter
(constant) that is chosen so as to correctly balance the
energy-like and entropy-like terms in the function [71].
Biological relevance of binding sites and their ranking with 
respect to the query protein
All binding site clusters are ranked in terms of their pre-
dicted biological relevance and similarity to the query.
First we assess the evolutionary conservation of binding
site clusters. Those sites which reoccur in diverse enough
protein complexes are ranked higher. Clusters that have
only one non-redundant member (after members with
more than 90% identity are removed) are considered "sin-
gletons" and are not assigned any score (ranked at the
bottom of the list). A "conservation score" is computed in
order to measure the diversity of cluster members and
how well the binding site is conserved across the
homologs. To do this, positional conservation in the
binding site multiple sequence alignment is calculated
using the Shannon entropy measure with the Henikoff-
Henikoff sequence weights. Sequence weights are esti-
mated using the complete sequences of neighbors aligned
with the query protein.
To account for evolutionary closeness of a given
binding site cluster to the query we use the sequence-
PSSM score and the average sequence identity between
the query and all cluster members calculated over the
whole structure-structure alignment (not just binding
sites). A position specific score matrix (PSSM) is con-
structed based on the binding site multiple alignment
using the implicit pseudo-count method of Gribskov,
McLachlan and Eisenberg [72]. The aligned binding
site region of the query protein is then scored against
the PSSM and a sequence-PSSM score is calculated. A
higher sequence-PSSM score points to a higher proba-
bility of this site being a biologically relevant site for
the query.
To rank the larger interfaces more highly we also cal-
culate the average number of interfacial contacts
which the binding site makes in the complex of the
corresponding homolog. All components of the rank-
ing score are then normalized and all clusters are
ranked with respect to the Z-scores. Any cluster with
all members binding non-biological small molecules is
disregarded.
The Z-score is calculated for each of these four corre-
sponding terms (i.e. conservation score, PSSM-score,
contact count, and percent sequence identity to query) in
the ranking scheme by subtracting the mean value and
dividing by the standard deviation obtained from the
score distribution of other binding site clusters for a given
query protein. The coefficients in front of each term in
the ranking score were calculated empirically. The com-
bined score is designed to rank the most biologically rele-
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